Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS)
FDA 510(k) clearance K211372 · decided 2021-06-02
Clearance details
- K-number
- K211372
- Device name
- Mahana Parallel Digital Cognitive Behavioral Therapy (CBT) Mobile Application for Irritable Bowel Syndrome (IBS)
- Applicant
- Mahana Therapeutics, Inc.
- Decision
- Substantially Equivalent
- Date received
- 2021-05-04
- Decision date
- 2021-06-02
- Days to decision
- 29 days
- Clearance type
- Special
- Product code
- QMY
- Device class
- 2
- Regulation number
- 876.5960
- Medical specialty
- Gastroenterology, Urology
- Advisory committee
- Gastroenterology, Urology
- Location
- San Francisco, CA, US
- Third-party review
- No
- Expedited review
- No
+ Add to Predicate Builder ◉ Watch Mahana Therapeutics
Need this as data, not a web page?
Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.
Similar devices under this product code
Devices cleared under the same product code - the starting set for predicate research.
| Record | Firm | Date |
|---|---|---|
| Regulora (K211463) | Metame Health, Inc. | 2021-11-24 |
| Parallel (DEN200029) | Mahana Therapeutics, Inc. | 2020-11-25 |
Recalls involving this device
No recalls on record reference this clearance.